Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
InChi: InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9
Ali S et al
mTOR kinase
24 and 72 hours) has the growth-inhibitory effect and leads to a dose-dependent decrease in numbers of SKOV-3 and OVCAR-3 cells
URB597 Size:2mg solid Antidiabetic actions of a non-agonistURB597, also known as KDS 4103, is a relatively selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH). FAAH is the primary degradatory enzyme for the endocannabinoid anandamide and, as such, inhibition of FAAH leads to an accumulation of anandamide in the CNS and periphery where it activates cannabinoid receptors. In pre clinical laboratory tests researchers found URB597 increased the production of endocannabinoids resulting in
US$ 38.00
US$ 72.00
US$ 38.00
US$ 88.00
US$ 38.00
US$ 75.00